Search

Legend Biotech Corp ADR

Fermé

SecteurSoins de santé

17.57 0.11

Résumé

Variation du prix de l'action

24h

Actuel

Min

17.18

Max

17.84

Chiffres clés

By Trading Economics

Revenu

88M

33M

Ventes

82M

388M

BPA

0.09

Marge bénéficiaire

8.568

Employés

3,200

EBITDA

92M

60M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+160.84% upside

Dividendes

By Acuity

Prochains Résultats

11 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-393M

3.6B

Ouverture précédente

17.46

Clôture précédente

17.57

Sentiment de l'Actualité

By Acuity

100%

0%

321 / 339 Classement par Healthcare

Legend Biotech Corp ADR Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 sept. 2026, 23:46 UTC

Legend Biotech Corp saw a modest increase in after-market trading, though it remains significantly below its 20-day moving average.

16 sept. 2026, 20:10 UTC

News

Legend Biotech Corp shares fell sharply today despite reporting second-quarter CARVYKTI sales of $657 million, marking the tenth consecutive session of declines.

15 sept. 2026, 22:02 UTC

Legend Biotech shares were roughly flat in after-market hours, remaining significantly below their 20-day moving average after nine consecutive lower sessions.

14 sept. 2026, 19:36 UTC

Shares of Legend Biotech Corp are lower today, continuing a broader trend. The stock remains significantly below its 20-day moving average.

11 sept. 2026, 23:26 UTC

Legend Biotech Corp shares are higher in after-market trading, reflecting notable gains since Friday's close amid speculation about Federal Reserve interest rate hikes.

9 sept. 2026, 20:07 UTC

Legend Biotech Corp shares are lower, continuing a trend of four consecutive daily declines. The stock remains below its 20-day moving average.

8 sept. 2026, 23:06 UTC

Shares of Legend Biotech Corp. are higher in after-market trading, recovering from a recent decline that saw three consecutive lower closes.

3 sept. 2026, 19:47 UTC

Shares of Legend Biotech Corp are lower today, despite earlier fluctuations that reached a session high. The stock remains above its 20-day moving average.

2 sept. 2026, 20:03 UTC

News

Legend Biotech shares are higher as management discusses CARVYKTI's commercial rollout and plans to expand manufacturing capabilities at the Morgan Stanley Global Healthcare Conference.

1 sept. 2026, 20:01 UTC

News

Legend Biotech will participate in the Morgan Stanley Global Healthcare Conference on September 15, 2026, as shares trade higher since Monday's close.

31 août 2026, 22:16 UTC

Legend Biotech Corp shares are higher in after-market hours, reflecting a shift from recent higher daily closes amid broader market reactions to inflation comments from the Fed.

28 août 2026, 20:07 UTC

Legend Biotech Corp shares are lower today, marking a fourth consecutive decline. Rising U.S. Treasury yields may be impacting investor sentiment.

27 août 2026, 22:26 UTC

Legend Biotech Corp. shares are higher in after-market trading, gaining slightly since Thursday's close amid routine market fluctuations.

26 août 2026, 23:11 UTC

Legend Biotech Corp shares are higher in after-market hours, reflecting the broader market's upward trend amid positive sentiment from major stocks.

25 août 2026, 19:06 UTC

Shares of Legend Biotech Corp are higher today, remaining above their 20-day moving average amid positive market sentiment linked to falling oil prices.

24 août 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, continuing a strong upward trend since Monday's close. The stock remains above its 20-day moving average.

21 août 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, maintaining a position near the upper end of their one-month trading range.

20 août 2026, 23:46 UTC

Legend Biotech Corp. shares are trading higher in after-market hours, diverging from broader market pressures amid rising crude oil prices and geopolitical tensions.

19 août 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, showing notable strength and exceeding the 20-day moving average. No specific news was identified.

18 août 2026, 20:03 UTC

Social Media

Legend Biotech Corp shares are higher today, buoyed by strong investor sentiment and analyst confidence in significant upside potential for the stock.

14 août 2026, 19:36 UTC

Shares of Legend Biotech Corp are trading higher, though fluctuations have been routine during the session. The stock remains below its 20-day moving average.

13 août 2026, 23:21 UTC

Legend Biotech Corp shares are higher in after-market hours, gaining traction following notable trading activity after Thursday's close. No specific news was identified.

12 août 2026, 23:16 UTC

Legend Biotech Corp. shares are higher in after-market hours, reflecting positive market conditions amid a Consumer Price Index report that met forecasts.

11 août 2026, 23:46 UTC

Shares of Legend Biotech Corp are higher in after-market hours, maintaining a position above the 20-day moving average amid stable trading conditions.

10 août 2026, 23:06 UTC

Shares of Legend Biotech are higher in after-market trading, settling above Monday's close despite mixed market sentiment and geopolitical tensions.

7 août 2026, 23:46 UTC

Shares of Legend Biotech Corp traded higher in after-market hours, amid a broader market context of a declining unemployment rate.

6 août 2026, 20:06 UTC

Legend Biotech Corp shares are higher today, reflecting a shift from recent trends. No specific company news was identified to explain this movement.

4 août 2026, 19:36 UTC

Legend Biotech Corp shares are higher today, recovering from an earlier low. Positive momentum persists despite a decline in U.S. core factory orders.

3 août 2026, 22:01 UTC

Shares of Legend Biotech Corp are higher in after-market trading, reflecting gains since Monday's close amid broader market advances in tech and oil-sensitive sectors.

31 juil. 2026, 23:56 UTC

Shares of Legend Biotech Corp. are higher in after-market trading, despite a slight decline earlier in the session and broader market weakness.

Comparaison

Variation de prix

Legend Biotech Corp ADR prévision

Objectif de Prix

By TipRanks

160.84% hausse

Prévisions sur 12 Mois

Moyen 45.856 USD  160.84%

Haut 74 USD

Bas 24 USD

Basé sur 9 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

9 ratings

5

Achat

4

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Legend Biotech Corp ADR

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation.